Showing results (91-100 of 134) with videos related to
Sort By:
Pageof 14
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 17, 2017
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real lifeV Cento, S Barbaliscia, I Lenci, et al.Reviews of Infectious Diseases|July 1, 1990
The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profilesR Yarchoan, H Mitsuya, J M Pluda, et al.Archives of Virology|April 6, 2011
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in CameroonJ Fokam, R Salpini, M M Santoro, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidineZ Hao, E E Stowe, G Ahluwalia, et al.Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Viral dynamics and mutations in the pol gene during primary HIV-1 infectionA Cenci, A Bertoli, G Tambussi, et al.AIDS Research and Human Retroviruses|April 18, 1998
Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovirL Rossi, G Brandi, G F Schiavano, et al.Journal of Virology|November 1, 1996
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivoP Bagnarelli, A Valenza, S Menzo, et al.HIV Medicine|September 2, 2006
Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant womenM C Marazzi, P Germano, G Liotta, et al.The New Microbiologica|January 14, 2005
Temporal change in the use of genotypic resistance testing over the years 1999--2003M Santoro, F Ceccherini-Silberstein, C Gori, et al.Pageof 14